About Jazz Pharmaceuticals
Jazz Pharmaceuticals is a company based in Dublin (Ireland) founded in 2003 by Bruce C Cozadd.. Jazz Pharmaceuticals has raised $265 million across 3 funding rounds from investors including KKR, Thoma Bravo and Longitude Capital. The company has 2,800 employees as of December 31, 2024. Jazz Pharmaceuticals has completed 5 acquisitions, including Cavion, Chimerix and EUSA Pharma. Jazz Pharmaceuticals offers products and services including Epidiolex, Xywav, and Defitelio. Jazz Pharmaceuticals operates in a competitive market with competitors including C4 Therapeutics, Erasca, MiRagen, Mereo BioPharma and Nimbus Therapeutics, among others.
- Headquarter Dublin, Ireland
- Employees 2800 as on 31 Dec, 2024
- Founders Bruce C Cozadd
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Jazz Pharmaceuticals Plc
-
Annual Revenue
$4.07 B6.12as on Dec 31, 2024
-
Net Profit
$560.12 M35.02as on Dec 31, 2024
-
EBITDA
$1.39 B6.84as on Dec 31, 2024
-
Total Equity Funding
$265 M (USD)
in 3 rounds
-
Latest Funding Round
$7 M (USD), Post-IPO
Jul 07, 2009
-
Investors
KKR
& 11 more
-
Employee Count
2800
as on Dec 31, 2024
-
Investments & Acquisitions
Cavion
& 4 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Jazz Pharmaceuticals
Jazz Pharmaceuticals is a publicly listed company on the NASDAQ with ticker symbol JAZZ in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Jazz Pharmaceuticals
Jazz Pharmaceuticals offers a comprehensive portfolio of products and services, including Epidiolex, Xywav, and Defitelio. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Cannabidiol-based treatment for epilepsy and seizures.
Oral solution for narcolepsy and related disorders.
Treatment for severe hepatic veno-occlusive disease.
Unlock access to complete
Unlock access to complete
Leadership Team
223 people
Software Development Team
103 people
Sales and Marketing
70 people
Senior Team
66 people
Product Management Team
56 people
Finance and Accounting
37 people
Data Analysis and Operations Team
31 people
Human Resources and Administration
30 people
Unlock access to complete
Funding Insights of Jazz Pharmaceuticals
Jazz Pharmaceuticals has successfully raised a total of $265M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $7 million completed in July 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $7.0M
-
First Round
First Round
(01 Apr 2003)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2009 | Amount | Post-IPO - Jazz Pharmaceuticals | Valuation |
investors |
|
| Mar, 2004 | Amount | Series B - Jazz Pharmaceuticals | Valuation | KKR | |
| Apr, 2003 | Amount | Series A - Jazz Pharmaceuticals | Valuation | Prospect Venture Partners , Versant Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Jazz Pharmaceuticals
Jazz Pharmaceuticals has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include KKR, Thoma Bravo and Longitude Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on life science sector
|
Founded Year | Domain | Location | |
|
Private markets investment management with strategies in equity, credit, and secondary investments.
|
Founded Year | Domain | Location | |
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Jazz Pharmaceuticals
Jazz Pharmaceuticals has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Cavion, Chimerix and EUSA Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer and commercializer of pharmaceutical medicines
|
2006 | ||||
|
Targeted therapies for neuropathic pain and brain cancer are developed.
|
2005 | ||||
|
Antiviral oral therapeutics are developed for infectious diseases and cancers.
|
2002 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Jazz Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Jazz Pharmaceuticals Comparisons
Competitors of Jazz Pharmaceuticals
Jazz Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as C4 Therapeutics, Erasca, MiRagen, Mereo BioPharma and Nimbus Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Jazz Pharmaceuticals
Frequently Asked Questions about Jazz Pharmaceuticals
When was Jazz Pharmaceuticals founded?
Jazz Pharmaceuticals was founded in 2003.
Where is Jazz Pharmaceuticals located?
Jazz Pharmaceuticals is headquartered in Dublin, Ireland.
Who is the current CEO of Jazz Pharmaceuticals?
Bruce C Cozadd is the current CEO of Jazz Pharmaceuticals. They have also founded this company.
Is Jazz Pharmaceuticals a funded company?
Jazz Pharmaceuticals is a funded company, having raised a total of $265M across 3 funding rounds to date. The company's 1st funding round was a Series A of $15M, raised on Apr 01, 2003.
How many employees does Jazz Pharmaceuticals have?
As of Dec 31, 2024, the latest employee count at Jazz Pharmaceuticals is 2,800.
What is the annual revenue of Jazz Pharmaceuticals?
Annual revenue of Jazz Pharmaceuticals is $4.07B as on Dec 31, 2024.
What does Jazz Pharmaceuticals do?
Jazz Pharmaceuticals was founded in 2003 and is headquartered in Dublin, Ireland. Biopharmaceutical products are developed and commercialized by the company to address unmet medical needs across various therapeutic areas. Clinical trial programs are conducted to support these medicines, alongside patient support resources. Research is prioritized based on patient requirements, with advancements made in treating specific conditions. Corporate giving and sustainability initiatives are also pursued.
Who are the top competitors of Jazz Pharmaceuticals?
Jazz Pharmaceuticals's top competitors include C4 Therapeutics, Erasca and Nimbus Therapeutics.
What products or services does Jazz Pharmaceuticals offer?
Jazz Pharmaceuticals offers Epidiolex, Xywav, and Defitelio.
Is Jazz Pharmaceuticals publicly traded?
Yes, Jazz Pharmaceuticals is publicly traded on NASDAQ under the ticker symbol JAZZ.
How many acquisitions has Jazz Pharmaceuticals made?
Jazz Pharmaceuticals has made 5 acquisitions, including Cavion, Chimerix, and EUSA Pharma.
Who are Jazz Pharmaceuticals's investors?
Jazz Pharmaceuticals has 12 investors. Key investors include KKR, Thoma Bravo, Longitude Capital, Adams Street Partners, and Versant Ventures.
What is Jazz Pharmaceuticals's ticker symbol?
The ticker symbol of Jazz Pharmaceuticals is JAZZ on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.